Related content

Screening for Cystic Fibrosis

By Cuckle H.   Murray J.  

Disease Management & Health Outcomes, Vol. 3, Iss. 4, 1998-04 ,pp. : 161-172

Adis International

Access to resources Recommend Favorite

Progress towards gene therapy for cystic fibrosis

By Tate Stephen   Elborn Stuart  

Expert Opinion on Drug Delivery, Vol. 2, Iss. 2, 2005-03 ,pp. : 269-280

Informa Healthcare

Access to resources Recommend Favorite

Outpatient Medication Costs of Patients with Cystic Fibrosis in Germany

By Eidt-Koch Daniela  

Applied Health Economics and Health Policy, Vol. 8, Iss. 2, 2010-03 ,pp. : 111-118

Adis International

Access to resources Recommend Favorite

Challenges and advances in the development of inhalable drug formulations for cystic fibrosis lung disease

By Ibrahim Basma M   Tsifansky Michael D   Yang Yan   Yeo Yoon  

Expert Opinion on Drug Delivery, Vol. 8, Iss. 4, 2011-04 ,pp. : 451-466

Informa Healthcare

Access to resources Recommend Favorite

Management of Patients with Cystic Fibrosis: Defining the Role of Inhaled Tobramycin

By Lamb H.M.   Goa K.L.  

Disease Management & Health Outcomes, Vol. 6, Iss. 2, 1999-08 ,pp. : 93-108

Adis International

Access to resources Recommend Favorite